FDA Allows Marketing of First WSI System for Digital Pathology

News   Apr 18, 2017 | Original story from FDA

 
FDA Allows Marketing of First WSI System for Digital Pathology
 
 
 

RELATED ARTICLES

Research Collaboration Aims to Improve Breast Cancer Diagnosis Using AI

News

A new project to explore how artificial intelligence (AI) could improve breast screening could potentially lead to more accurate detection of cancers.

READ MORE

Training Evolution in Pathology Needed to Deliver Precision Medicine

News

The future delivery of precision medicine is at risk unless pathology training programmes evolve to embrace genomics, warn UK researchers.

READ MORE

Quest Diagnostics Acquires California Laboratory Associates

News

Transaction expands access to innovative, high-value diagnostic information services in Southern California.

READ MORE

 

Comments | 0 ADD COMMENT

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE